Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php |
Title | IO Biotech - Unleashing the Power of Targeted Immunotherapiesfor |
Description | IO Biotech is a clinical stage biotech company developing disruptive immune modulating anti-cancer |
Keywords | N/A |
WebSite | iobiotech.com |
Host IP | 77.111.240.115 |
Location | France |
Site | Rank |
US$12,944,500
Last updated: 2022-06-21 17:16:23
iobiotech.com has Semrush global rank of 817,668. iobiotech.com has an estimated worth of US$ 12,944,500, based on its estimated Ads revenue. iobiotech.com receives approximately 1,493,597 unique visitors each day. Its web server is located in France, with IP address 77.111.240.115. According to SiteAdvisor, iobiotech.com is safe to visit. |
Purchase/Sale Value | US$12,944,500 |
Daily Ads Revenue | US$11,949 |
Monthly Ads Revenue | US$358,464 |
Yearly Ads Revenue | US$4,301,557 |
Daily Unique Visitors | 99,574 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
iobiotech.com. | A | 3599 | IP: 77.111.240.115 |
iobiotech.com. | AAAA | 3600 | IPV6: 2a02:2350:5:109:809e:f21c:7e1a:d9b2 |
iobiotech.com. | NS | 14400 | NS Record: ns01.one.com. |
iobiotech.com. | NS | 14400 | NS Record: ns02.one.com. |
iobiotech.com. | MX | 3600 | MX Record: 0 iobiotech-com.mail.protection.outlook.com. |
iobiotech.com. | TXT | 3519 | TXT Record: MS=ms16135759 |
iobiotech.com. | TXT | 3519 | TXT Record: v=spf1 include:spf.protection.outlook.com include:_custspf.one.com -all |
Home About us Overview Leadership Board of Directors Scientific Advisory Board Science T-Win technology platform Pipeline Programs Publications Patients Investors Careers Contact Contact information Privacy Policy Select Page Unleashing the Power of Targeted Immunotherapies for Cancer Read more view our pipeline subscribe to our newsletter About us IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on our T-win® technology platform. Our product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. read more Latest news IO Biotech Announces Year-End Results for 2021 read more 4 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 5 Home About us Science Patients Investors Careers Contact Privacy Policy | Cookie Policy Follow Copyright © 2021 IO Biotech |
HTTP/1.1 200 OK Date: Sat, 23 Oct 2021 18:33:33 GMT Server: Apache X-Powered-By: PHP/7.4.25 P3P: CP="NOI ADM DEV PSAi COM NAV OUR OTRo STP IND DEM" Expires: Wed, 17 Aug 2005 00:00:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Set-Cookie: 76c188612503bf85a6bdfcf6ff9c16d9=8721eb8fcfaec8525ec130c696c7740c; path=/; domain=.iobiotech.com; HttpOnly Last-Modified: Sat, 23 Oct 2021 18:33:33 GMT Content-Type: text/html; charset=utf-8 X-Varnish: 862622186 Age: 0 Via: 1.1 varnish (Varnish/7.0) Connection: keep-alive |
Domain Name: IOBIOTECH.COM Registry Domain ID: 1894161261_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.one.com Registrar URL: http://www.one.com Updated Date: 2020-12-06T00:31:05Z Creation Date: 2015-01-05T10:17:27Z Registry Expiry Date: 2022-01-05T10:17:27Z Registrar: One.com A/S Registrar IANA ID: 1462 Registrar Abuse Contact Email: abuse@one.com Registrar Abuse Contact Phone: +45 44451220 Domain Status: ok https://icann.org/epp#ok Name Server: NS01.ONE.COM Name Server: NS02.ONE.COM DNSSEC: signedDelegation DNSSEC DS Data: 32717 13 2 830603D03913DD186DE2657F710AE9464D9E558BB6862A9C400DFDF2C8960E0C >>> Last update of whois database: 2021-09-12T04:39:13Z <<< |